News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
341,351 Results
Type
Article (20329)
Company Profile (140)
Press Release (320882)
Section
Business (108515)
Career Advice (875)
Deals (19429)
Drug Delivery (91)
Drug Development (51879)
Employer Resources (79)
FDA (7990)
Job Trends (7987)
News (191665)
Policy (17888)
Tag
Academia (742)
Alliances (28560)
Alzheimer's disease (582)
Approvals (7964)
Artificial intelligence (87)
Bankruptcy (171)
Best Places to Work (5684)
Biosimilars (68)
Biotechnology (64)
Breast cancer (74)
Cancer (672)
Cardiovascular disease (65)
Career advice (709)
Cell therapy (110)
Clinical research (42946)
Collaboration (255)
Compensation (87)
COVID-19 (1089)
C-suite (67)
Data (760)
Diabetes (103)
Diagnostics (1822)
Drug pricing (96)
Earnings (39790)
Employer resources (73)
Events (49324)
Executive appointments (233)
FDA (8299)
Funding (180)
Gene therapy (92)
GLP-1 (498)
Government (1824)
Healthcare (6066)
Infectious disease (1141)
Inflammatory bowel disease (71)
Interviews (115)
IPO (7640)
Job creations (2543)
Job search strategy (650)
Layoffs (254)
Legal (4299)
Lung cancer (102)
Manufacturing (137)
Medical device (2278)
Medtech (2281)
Mergers & acquisitions (11859)
Metabolic disorders (348)
Neuroscience (771)
NextGen Class of 2024 (2374)
Non-profit (921)
Northern California (744)
Obesity (224)
Opinion (174)
Patents (79)
People (33861)
Pharmaceutical (78)
Phase I (13343)
Phase II (18139)
Phase III (14653)
Pipeline (315)
Policy (73)
Postmarket research (1730)
Preclinical (4681)
Radiopharmaceuticals (160)
Rare diseases (155)
Real estate (3228)
Regulatory (12527)
Research institute (834)
Resumes & cover letters (138)
Southern California (683)
Startups (2051)
United States (6769)
Vaccines (220)
Weight loss (189)
Date
Today (58)
Last 7 days (365)
Last 30 days (1465)
Last 365 days (18138)
2024 (17628)
2023 (20199)
2022 (27131)
2021 (28112)
2020 (26142)
2019 (20729)
2018 (15968)
2017 (17935)
2016 (16776)
2015 (19615)
2014 (15445)
2013 (13035)
2012 (14034)
2011 (14299)
2010 (13194)
Location
Africa (413)
Asia (24767)
Australia (3193)
California (1675)
Canada (813)
China (173)
Colorado (71)
Connecticut (67)
Europe (57998)
Florida (241)
Illinois (166)
Indiana (123)
Japan (63)
Maryland (249)
Massachusetts (1423)
Minnesota (97)
New Jersey (644)
New York (476)
North Carolina (372)
Northern California (744)
Ohio (64)
Pennsylvania (409)
South America (618)
Southern California (683)
Texas (226)
Washington State (158)
341,351 Results for "sinclair pharma plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Angle PLC Announces New Commercial Agreement with Large Pharma
ANGLE plc is delighted to announce that it has signed a supplier agreement to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies.
May 3, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 6, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
December 10, 2024
·
3 min read
Press Releases
Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market
July 26, 2024
·
2 min read
Business
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Poolbeg Pharma, a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces its audited results for the year ended 31 December 2023.
April 30, 2024
·
4 min read
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA
Poolbeg Pharma announces that, further to its announcement on20 March 2024,the Company has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.
May 1, 2024
·
5 min read
FDA
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
June 26, 2024
·
10 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Deals
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate
Poolbeg Pharma announces that it has entered into an exclusive 12-month option agreement with Silk Road Therapeutics Inc, for a nominal fee, to acquire a novel topical muco-adherent formulation of Pentoxifylline for the treatment of oral ulcers in patient’s suffering from Behçet’s Disease.
April 30, 2024
·
8 min read
1 of 34,136
Next
